Capital II Llc Orbimed serves as Executive at AVANIR PHARMACEUTICALS, where they oversee executive responsibilities. Since joining the company, Capital II Llc Orbimed has executed 2 insider transactions totaling $6.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 31, 2006 involved selling 629,121 shares valued at $6.2M.
Capital II Llc Orbimed currently holds 1,706,137 shares of AVANIR PHARMACEUTICALS (AVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital II Llc Orbimed has been a net seller of AVN stock. They have purchased $0 and sold $6.6M worth of shares.
Capital II Llc Orbimed's most recent insider trade was on May 31, 2006, when they sold 629,121 shares at $9.79 per share.
Get notified when new Form 4 filings are submitted
| $18.14 |
| Discretionary |